Acadian Asset Management
LXRX icon

Acadian Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Acadian Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
696,617
+251,329
+56% +$490K ﹤0.01% 1123
2026
Q1 		$693K Sell
445,288
-194,842
-30% -$283K ﹤0.01% 1268
2025
Q4 		$732K Buy
640,130
+603,225
+1,635% +$829K ﹤0.01% 1203
2025
Q3 		$49K Buy
+36,905
New +$41.9K ﹤0.01% 1647
2025
Q2 		– Sell
-573,688
Closed -$263K – 1767
2025
Q1 		$263K Buy
+573,688
New +$362K ﹤0.01% 1203
2024
Q4 		– Sell
-58,007
Closed -$91K – 1941
2024
Q3 		$91K Buy
+58,007
New +$103K ﹤0.01% 1618
2021
Q2 		– Sell
-462,296
Closed -$2.71M – 2122
2021
Q1 		$2.71M Sell
462,296
-1,231,739
-73% -$8.53M 0.01% 649
2020
Q4 		$5.79M Sell
1,694,035
-160,275
-9% -$306K 0.02% 466
2020
Q3 		$2.67M Buy
1,854,310
+191,384
+12% +$341K 0.01% 592
2020
Q2 		$3.31M Buy
1,662,926
+586,865
+55% +$1.15M 0.01% 581
2020
Q1 		$2.1M Buy
1,076,061
+911,113
+552% +$2.71M 0.01% 589
2019
Q4 		$685K Buy
+164,948
New +$635K ﹤0.01% 989
2016
Q4 		– Sell
-4,886
Closed -$88K – 1710
2016
Q3 		$88K Sell
4,886
-55,250
-92% -$889K ﹤0.01% 1084
2016
Q2 		$863K Buy
+60,136
New +$816K ﹤0.01% 657

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Acadian Asset Management's LXRX Position: Q2 2026 in Review

Acadian Asset Management increased its Lexicon Pharmaceuticals (LXRX) stake by 56% in Q2 2026, buying an estimated $490K and bringing the position to 696,617 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1123.

Acadian Asset Management first reported a position in LXRX in Q2 2016 and has held it in 14 quarters since. The position peaked at $5.79M in Q4 2020. 148 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Acadian Asset Management held 696,617 shares of Lexicon Pharmaceuticals worth $1.67M as of Q2 2026.
  • Acadian Asset Management bought 251,329 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $490K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1123 holding.
  • Acadian Asset Management first reported a position in Lexicon Pharmaceuticals in Q2 2016 and has held it in 14 quarters since.
  • Acadian Asset Management's Lexicon Pharmaceuticals position peaked at $5.79M in Q4 2020.
  • 148 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.